21 results on '"Bloch AB"'
Search Results
2. The need for epidemic intelligence... including commentary by Sbarbaro JA.
- Author
-
Bloch AB, Onorato IM, Ihle WW, Hadler JL, Hayden CH, and Snider DE Jr.
- Abstract
THE PAST DECADE has witnessed an unprecedented upturn in tuberculosis morbidity and outbreaks of difficult-to treat and highly lethal multidrug-resistant tuberculosis. In the early 1990s, a national consensus developed among public health officials to define more comprehensively the problem, and in January 1993 expanded tuberculosis surveillance was implemented nationwide. Carefully selected epidemiologic and case management variables were added to the Report of Verified Case of Tuberculosis form. Information is collected on the health status and treatment of patients, including human immunodeficiency virus status, drug susceptibility test results, and the initial drug regimen. Completion of therapy and use of directly observed therapy are also monitored. The new surveillance system allows a comparison of the quality of care of patients in the public and private sectors. Additional epidemiologic variables include membership in high-risk groups (the homeless, residents of correctional or long-term care facilities, migrant workers, health care workers, and correctional employees) and substance abuse (injecting drug use, non-injecting drug use, and excess alcohol use). The additional information derived from expanded tuberculosis surveillance is crucial to optimal patient management, policy development, resource allocation, as well as program planning, implementation, and evaluation at Federal, State, and local levels. [ABSTRACT FROM AUTHOR]
- Published
- 1996
3. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
- Author
-
Driver CR, Frieden TR, Bloch AB, and Onorato IM
- Abstract
The authors assessed drug susceptibility patterns among tuberculosis patients reported to the New York City Department of Health in the first quarters of 1991 and 1992. Resistance to one or more drugs was seen in 26 percent (137 divided into 520) in 1991 and 24 percent (122 divided into 517) in 1992. Resistance to isoniazid was seen in 22 percent and 19 percent of patients in 1991 and 1992, respectively; resistance to rifampin in 15 percent and 14 percent; and to both isoniazid and rifampin in 15 percent and 14 percent. Combined resistance to four first line drugs (isoniazid, rifampin, streptomycin, and ethambutol) was seen in 6 percent (1991) and 8 percent (1992). Patients with organisms resistant to both isoniazid and rifampin were as likely among U.S. born as among foreign born, and younger patients were more likely than older patients to have isoniazid and rifampin resistant organisms. These findings underscore the importance of obtaining susceptibility testing in all patients who have cultures positive for Mycobacterium tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 1994
4. Nosocomial transmission of tuberculosis associated with a draining abscess.
- Author
-
Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM, Hutton, M D, Stead, W W, Cauthen, G M, Bloch, A B, and Ewing, W M
- Abstract
Nine secondary cases of tuberculosis and 59 tuberculin skin test conversions occurred after exposure to a hospitalized patient with a large tuberculous abscess of the hip and thigh. Among 442 tuberculin-negative hospital employees, the relative risk of skin test conversion associated with recalled exposure to the patient was 14.0 (95% confidence limits, 6.8, 28.7). Four of 5 surgical suite employees who assisted with incision and debridement of the abscess had skin test conversions, as did 85% of 33 employees on a general medical floor who recalled exposure to the patient and 30% of 20 intensive care unit employees who recalled exposure. The prevalence of tuberculin reactivity in visitors and other patients on two floors also showed a strong association with exposure to the patient. A high concentration of Mycobacterium tuberculosis in the abscessed tissue, disturbance of the surface of liquid drainage from the abscess by irrigations and by the agitated behavior of the patient, and positive air pressure in the patient's room are factors that appear to have contributed to the high risk of tuberculosis transmission. [ABSTRACT FROM AUTHOR]
- Published
- 1990
5. Prevalence of Obesity-Related Disease in a Danish Population - The Results of an Algorithm-Based Screening Program.
- Author
-
Juhl CB, Bladbjerg EM, Gram B, Knudsen T, Lauridsen MM, Nygaard NB, Drøjdahl Ryg N, Skadhauge L, and Münster AB
- Abstract
Purpose: The prevalence of obesity continues to rise. People with obesity are at increased risk of several diseases. We tested an algorithm-based screening program for people with a BMI above 30 kg/m
2 and present data on the prevalence of previously undiagnosed obesity-related diseases., Patients and Methods: Seven hundred and sixty-nine persons with BMI > 30 kg/m2 and age 18-60 years were screened for diabetes (assessed by glycosylated hemoglobin and oral glucose tolerance test at HbA1c 43-48 mmol/mol), sleep apnea (screened by questionnaires and assessed by cardiorespiratory monitoring at indication of sleep disorder), liver steatosis or liver fibrosis (assessed by biochemistry and fibroscan) and arterial hypertension (assessed by both office and 24-hour blood pressure measurement). A reference group of people with a BMI of 18.5-29.9 kg/m2 was established., Results: Of those referred, 73.0% were women. We identified new diabetes in 4.2%, prediabetes in 9.1%, moderate-to-severe sleep apnea in 25.1%, increased liver fat and increased liver stiffness in 68.1% and 17.4%, respectively, and hypertension or masked hypertension in 19.0%. The prevalence of diseases was much higher among men and increased with BMI. Except for hypertension, we found few participants with undiagnosed disease in the reference group., Conclusion: An algorithm-based screening program is feasible and reveals undiagnosed obesity-related disease in a large proportion of the participants. The disproportional referral pattern calls for a tailored approach aiming to include more men with obesity., Trial Registration: Inclusion of the non-obese group was approved by the Scientific Ethics Committee of The Region of Southern Denmark (project identification number: S-20210091), and the study was reported at clinicaltrials.gov (NCT05176132)., Competing Interests: The authors report no conflicts of interest in this work., (© 2024 Juhl et al.)- Published
- 2024
- Full Text
- View/download PDF
6. Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study.
- Author
-
Rudolfsen JH, Gluud LL, Grønbæk H, Jensen MK, Vyberg M, Olsen J, Bo Poulsen P, Hovelsø N, Gregersen NT, Thomsen AB, and Jepsen P
- Subjects
- Humans, Denmark epidemiology, Female, Male, Middle Aged, Adult, Biopsy economics, Liver Cirrhosis economics, Liver Cirrhosis mortality, Liver Cirrhosis epidemiology, Aged, Insurance, Disability economics, Insurance, Disability statistics & numerical data, Non-alcoholic Fatty Liver Disease economics, Non-alcoholic Fatty Liver Disease mortality, Non-alcoholic Fatty Liver Disease epidemiology, Registries, Health Care Costs, Cost of Illness
- Abstract
Introduction and Objectives: Studies on the societal burden of patients with biopsy-confirmed non-alcoholic fatty liver disease (NAFLD) are sparse. This study examined this question, comparing NAFLD with matched reference groups., Materials and Methods: Nationwide Danish healthcare registers were used to include all patients (≥18 years) diagnosed with biopsy-verified NAFLD (1997-2021). Patients were classified as having simple steatosis or non-alcoholic steatohepatitis (NASH) with or without cirrhosis, and all matched with liver-disease free reference groups. Healthcare costs and labour market outcomes were compared from 5 years before to 11 years after diagnosis. Patients were followed for 25 years to analyse risk of disability insurance and death., Results: 3,712 patients with biopsy-verified NASH (n = 1,030), simple steatosis (n = 1,540) or cirrhosis (n = 1,142) were identified. The average total costs in the year leading up to diagnosis was 4.1-fold higher for NASH patients than the reference group (EUR 6,318), 6.2-fold higher for cirrhosis patients and 3.1-fold higher for simple steatosis patients. In NASH, outpatient hospital contacts were responsible for 49 % of the excess costs (EUR 3,121). NASH patients had statistically significantly lower income than their reference group as early as five years before diagnosis until nine years after diagnosis, and markedly higher risk of becoming disability insurance recipients (HR: 4.37; 95 % CI: 3.17-6.02) and of death (HR: 2.42; 95 % CI: 1.80-3.25)., Conclusions: NASH, simple steatosis and cirrhosis are all associated with substantial costs for the individual and the society with excess healthcare costs and poorer labour market outcomes., Competing Interests: Conflicts of interest Jan Håkon Rudolfsen and Jens Olsen are employees at EY, which is a paid vendor of Pfizer Denmark Aps. Lise Lotte Gluud, Henning Grønbæk, Majken K. Jensen, Mogens Vyberg and Peter Jepsen were paid by Pfizer Denmark Aps. for their work as members of the Study Steering Committee. Peter Bo Poulsen, Nanna Hovelsø, Nikolaj Ture Gregersen and Anne Bloch Thomsen are employees of Pfizer Denmark Aps. Peter Bo Poulsen, Nanna Hovelsø, and Anne Bloch Thomsen owns shares from Pfizer Inc. The authors report no other conflicts of interest in this work. Full ICMJE Disclosure forms are submitted for each co-author., (Copyright © 2024. Published by Elsevier España, S.L.U.)
- Published
- 2024
- Full Text
- View/download PDF
7. Effect of Plasma Fibrinogen Levels on the Risk of Stroke in Patients with Type 2 Diabetes: A Systematic Review.
- Author
-
Daugaard N, Bladbjerg EM, Maat MPM, and Münster AB
- Abstract
Aims In this systematic review, we assessed the literature on the association between fibrinogen levels and stroke in patients with type 2 diabetes (T2D). Methods MEDLINE and Ovid searches of English reports were performed on the relation between fibrinogen, stroke, and T2D in humans. The search was completed on May 4, 2023. Studies were eligible when T2D patients ≥18 years had stroke confirmed by computed tomography or magnetic resonance imaging, plasma fibrinogen was measured, and a relation between fibrinogen and stroke in T2D patients was reported. Screening of reports and extraction of data were done independently by two authors, and study quality was assessed by predefined issues. Results Five studies of different designs were included. Three studies reported on significantly increased fibrinogen levels in T2D patients with stroke compared with T2D patients without stroke. Two studies did not observe a significant association between fibrinogen levels and stroke risk. Conclusion No consistent association was observed between fibrinogen levels and risk of stroke in T2D patients. Due to differences in study design, low sample size, and poorly defined study participants, larger and better-defined studies are needed to elucidate the role of fibrinogen as a stroke risk marker in T2D patients., Competing Interests: Conflict of Interest N.D. received financial support from Steno Diabetes Center Odense., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).)
- Published
- 2024
- Full Text
- View/download PDF
8. Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study.
- Author
-
Wrønding T, Vomstein K, Bosma EF, Mortensen B, Westh H, Heintz JE, Mollerup S, Petersen AM, Ensign LM, DeLong K, van Hylckama Vlieg JET, Thomsen AB, and Nielsen HS
- Abstract
Background: Vaginal dysbiosis covers imbalances in the vaginal microbiota, defined by altered composition of bacteria, viruses, and fungi and is associated with euploid pregnancy losses, premature birth, infertility, or bacterial vaginosis. A large proportion of women who have vaginal dysbiosis do not experience any symptoms. Antibiotics are the traditional treatment, recently combined with local probiotics in some cases. Vaginal Microbiota Transplantation (VMT) with eubiotic vaginal bacterial microbiota after antibiotic eradication of pathogens has successfully been performed in a case study with five patients, but no VMT has been performed without the use of antibiotics., Methods: This is a proof of concept case study. The patient was found to have vaginal dysbiosis at the RPL clinic at Copenhagen University Hospital Hvidovre, Denmark on the 23rd of June 2021. She was offered and accepted to receive experimental treatment in the form of a VMT as a compassionate use case. VMT is the transfer of cervicovaginal secretions (CVS) from a healthy donor with a Lactobacillus -dominant vaginal microbiome to a recipient with a dysbiotic vaginal microbiome. CVS is a mixture of e.g., mucus, bacteria, metabolites present in the vaginal canal. Potential donors were thoroughly screened for the absence of STIs, and the most suitable donor sample for the specific patient in this study was determined via an in vitro microbiome competition assay., Findings: A 30-year-old patient with one livebirth and a complicated pregnancy history of two stillbirths and 1 s trimester pregnancy loss in gestational weeks 27 (2019), 17 (2020) and 23 (2020) respectively with complaints of vaginal irritation and discharge that had aggravated in all her pregnancies. Her vaginal microbiome composition showed a 90% dominance of Gardnerella spp. After one VMT there was a complete shift in microbiome composition to 81.2% L. crispatus and 9% L. jensenii with a concurrent resolvement of vaginal symptoms. Single nucleotide polymorphism-analysis confirmed her microbiome to be of donor origin and it remain stable now 1.5 years after the VMT. Five months after the VMT she became pregnant and has successfully delivered a healthy baby at term., Interpretation: Here we report a successful VMT with confirmed donor strain engraftment followed by a successful pregnancy and delivery after a series of late pregnancy losses/stillbirths. Findings suggest that VMT is a potential treatment for severe vaginal dysbiosis. Further, larger studies are required., Funding: The study was partially funded (i.e., analysis costs) by Freya Biosciences Aps, Fruebjergvej, 2100 Copenhagen, Denmark., Competing Interests: Elleke F. Bosma, Brynjulf Mortensen, Kevin DeLong and Johan van Hylckama Vlieg are employees of Freya Biosciences. Johan van Hylckama Vlieg, Anne Bloch Thomsen and Laura Ensign are shareholders of Freya Biosciences. Elleke F. Bosma and Brynjulf Mortensen are listed as inventors on a patent application filed on the use of VMT for RPL. Laura Ensign is the Chair of the Scientific Advisory Board for Freya Biosciences, receives consulting payments from Freya Biosciences, and is an inventor on patent applications related to VMT that are owned by Johns Hopkins University. Anne Bloch Thomsen is a full-time employee of Pfizer as Country Medical Director, CMO of Pfizer Denmark and Iceland and is on the Board of Pfizer Denmark, and is a board member of EMPROS Pharma Sweden. Henriette Svarre Nielsen has received scientific grants from Freya Biosciences, Ferring Pharmaceuticals, BioInnovation Institute, Ministry of Education, Novo Nordisk Foundation, Augustinus Fonden, Oda og Hans Svenningsens Fond, Demant Fonden, and Ole Kirks Fond. HSN received personal payment or honoraria for lectures and presentations from Ferring Pharmaceuticals, Merck, Astra Zeneca, Cook Medical, and IBSA Nordic. Henrik Westh, Andreas Munk Petersen Sarah Mollerup received materials for the study funded by Freya Biosciences and paid to institution. Tine Wrønding, Kilian Vomstein and Julie Elm Heinz do not have any conflicts of interest regarding this publication., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
9. How to increase value and reduce waste in research: initial experiences of applying Lean thinking and visual management in research leadership.
- Author
-
Hildebrandt MG, Kidholm K, Pedersen JE, Naghavi-Behzad M, Knudsen T, Krag A, Ryg J, Gerke O, Lassen AT, Ellingsen T, Ditzel HJ, Andersen V, Langhoff A, Nielsen G, Masud T, Münster AB, Kyvik K, and Brixen K
- Subjects
- Humans, Efficiency, Organizational, Leadership, Efficiency
- Abstract
Waste in research has been well documented, but initiatives to reduce it are scarce. Here, we share our initial experiences of implementing Lean thinking and visual management into hospital research units in the Region of Southern Denmark. A Transformation Guiding Team (TGT) anchored in the top management was established with participation from leaders, researchers and patient representatives. The role of the TGT was to implement Lean methods, considering patients as primary end-users of the research results. This is in line with an explicit decision on setting patient values first in clinical settings at participating hospitals. The leaders of the research units were instructed in Lean thinking and Lean methods during a five-module course focusing on increasing value and reducing waste in research production. Initial experiences were that Lean tools could create a patient-centred vision that through visual management could identify waste in work processes. Concerns were lack of evidence for using Lean methods in research leadership and that the model itself could be a time consumer. Some lessons learnt were that adding Lean tools in research leadership should not just provide increased research productivity, but also improve other important key performance indicators such as quality of research and patient-relevant results. We intend to evaluate the value of the initiative by follow-up research and publish the outcome of key behavioural and key performance indicators., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
10. Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation.
- Author
-
Rasmussen PV, Dalgaard F, Gislason GH, Brandes A, Johnsen SP, Grove EL, Torp-Pedersen C, Dybro L, Harboe L, Münster AB, Pedersen L, Blanche P, Pallisgaard JL, and Hansen ML
- Abstract
Aims: Gastrointestinal bleeding (GI-bleeding) is frequent in patients with atrial fibrillation (AF) treated with oral anticoagulation (OAC) therapy. We sought to investigate to what extent lower GI-bleeding represents the unmasking of an occult colorectal cancer., Methods and Results: A total of 125 418 Danish AF patients initiating OAC therapy were identified using Danish administrative registers. Non-parametric estimation and semi-parametric absolute risk regression were used to estimate the absolute risks of colorectal cancer in patients with and without lower GI-bleeding. During a maximum of 3 years of follow-up, we identified 2576 patients with lower GI-bleeding of whom 140 patients were subsequently diagnosed with colorectal cancer within the first year of lower GI-bleeding. In all age groups, we observed high risks of colorectal cancer after lower GI-bleeding. The absolute 1-year risk ranged from 3.7% [95% confidence interval (CI) 2.2-6.2] to 8.1% (95% CI 6.1-10.6) in the age groups ≤65 and 76-80 years of age, respectively. When comparing patients with and without lower GI-bleeding, we found increased risk ratios of colorectal cancer across all age groups with a risk ratio of 24.2 (95% CI 14.5-40.4) and 12.3 (95% CI 7.9-19.0) for the youngest and oldest age group of ≤65 and >85 years, respectively., Conclusion: In anticoagulated AF patients, lower GI-bleeding conferred high absolute risks of incident colorectal cancer. Lower GI-bleeding should not be dismissed as a benign consequence of OAC therapy but always examined for a potential underlying malignant cause., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
11. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
- Author
-
Seidenfaden SC, Kjerulff JL, Juul N, Kirkegaard H, Møller MF, Münster AB, and Bøtker MT
- Subjects
- Aged, Biomarkers blood, Brain Injuries, Traumatic blood, Brain Injuries, Traumatic diagnosis, Cohort Studies, Emergency Medical Services, Female, Glasgow Coma Scale, Humans, Male, Middle Aged, Prospective Studies, Tomography, X-Ray Computed methods, Brain Concussion blood, Brain Concussion diagnosis, Glial Fibrillary Acidic Protein blood, S100 Calcium Binding Protein beta Subunit blood
- Abstract
Background: The biomarker serum S100 calcium-binding protein B (S100B) is used in in-hospital triage of adults with mild traumatic brain injury to rule out intracranial lesions. The biomarker glial fibrillary acidic protein (GFAP) is suggested as a potential diagnostic biomarker for traumatic brain injury. The aim of this study was to investigate the diagnostic accuracy of early prehospital S100B and GFAP measurements to rule out intracranial lesions in adult patients with mild traumatic brain injury., Methods: Prehospital and in-hospital blood samples were drawn from 566 adult patients with mild traumatic brain injury (Glasgow Coma Scale Score 14-15). The index test was S100B and GFAP concentrations. The reference standard was endpoint adjudication of the traumatic intracranial lesion based on medical records. The primary outcome was prehospital sensitivity of S100B in relation to the traumatic intracranial lesion., Results: Traumatic intracranial lesions were found in 32/566 (5.6%) patients. The sensitivity of S100B > 0.10 μg/L was 100% (95%CI: 89.1;100.0) in prehospital samples and 100% (95% CI 89.1;100.0) in in-hospital samples. The specificity was 15.4% (95%CI: 12.4;18.7) in prehospital samples and 31.5% (27.5;35.6) in in-hospital samples. GFAP was only detected in less than 2% of cases with the assay used., Conclusion: Early prehospital and in-hospital S100B levels < 0.10 μg/L safely rules out traumatic intracranial lesions in adult patients with mild traumatic brain injury, but specificity is lower with early prehospital sampling than with in-hospital sampling. The very limited cases with values detectable with our assay do not allow conclusions to be draw regarding the diagnostic accuracy of GFAP., Trial Registration: ClinicalTrials.gov identifier: NCT02867137 .
- Published
- 2021
- Full Text
- View/download PDF
12. Influence of Simulated Pre-Hospital Transport, Time to Analysis, and Storage Temperature on S100 Calcium-Binding Protein B Values.
- Author
-
Kjerulff JL, Seidenfaden SC, Juul N, Møller MF, Munster AB, and Bøtker MT
- Subjects
- Aged, Biomarkers blood, Blood Specimen Collection methods, Brain Concussion diagnosis, Brain Concussion surgery, Female, Humans, Male, Middle Aged, Preoperative Care methods, Prospective Studies, Temperature, Time Factors, Transportation of Patients methods, Blood Specimen Collection standards, Brain Concussion blood, Preoperative Care standards, S100 Calcium Binding Protein beta Subunit blood, Transportation of Patients standards
- Abstract
According to in-hospital guidelines, the biomarker, S100 calcium-binding protein B (S100B), is used to rule out intracranial lesions in mild-moderate traumatic brain injury (TBI). It is currently investigated whether S100B is applicable in a pre-hospital setting. The aim was to compare S100B values and hemolysis index in blood samples drawn and stored under simulated pre-hospital conditions to standardized blood samples. Thirty patients undergoing craniotomy at Department of Neurosurgery, Aarhus University Hospital (Aarhus, Denmark) each had six blood samples drawn. Two samples, drawn in in-hospital standardized Beckton Dickinson tubes and pre-hospital Monovette tubes, respectively, were stored as references at 21°C for 30 min. Two samples were stored at 15°C and 29°C, respectively, one sample was stored at prolonged time (60 min), and one sample was transported for 30 min before centrifugation. S100B values were compared by equivalence test with a pre-defined equivalence margin of ±8.5%. There was no clinically relevant difference between samples stored in different tubes, at various temperatures, or time to analysis compared to reference samples. Transported samples had an 11.5% (90% confidence interval [CI], 6.55; 16.61) higher median S100B value and a 430% (95% CI, 279.6; 661.4) higher median hemolysis index compared to reference samples. Three of 30 (10%) patients had an S100B value above guideline cutoff in the transported sample, which was not found in reference samples (false positive). There were no false negatives. In conclusion, S100B values were not influenced by different tubes, temperatures, and time to analysis. Transported samples had higher median S100B values and hemolysis, icterus, and lipemia index compared to reference samples.
- Published
- 2020
- Full Text
- View/download PDF
13. Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure.
- Author
-
Marso SP, Baeres FMM, Bain SC, Goldman B, Husain M, Nauck MA, Poulter NR, Pratley RE, Thomsen AB, and Buse JB
- Subjects
- Aged, Cardiovascular Diseases drug therapy, Cardiovascular Diseases mortality, Death, Double-Blind Method, Female, Hospitalization trends, Humans, Internationality, Male, Middle Aged, Treatment Outcome, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 mortality, Heart Failure drug therapy, Heart Failure mortality, Hypoglycemic Agents therapeutic use, Liraglutide therapeutic use
- Abstract
Background: More data regarding effects of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes (T2D) and heart failure (HF) are required., Objectives: The purpose of this study was to investigate the effects of liraglutide on cardiovascular events and mortality in LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) participants, by HF history., Methods: In the multinational, double-blind, randomized LEADER trial, 9,340 patients with T2D and high cardiovascular risk were assigned 1:1 to liraglutide (1.8 mg daily or maximum tolerated dose up to 1.8 mg daily) or placebo plus standard care, and followed for 3.5 to 5 years. New York Heart Association (NYHA) functional class IV HF was an exclusion criterion. The primary composite major adverse cardiovascular events outcome was time to first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. Post hoc Cox regression analyses of outcomes by baseline HF history were conducted., Results: At baseline, 18% of patients had a history of NYHA functional class I to III HF (liraglutide: n = 835 of 4,668; placebo: n = 832 of 4,672). Effects of liraglutide versus placebo on major adverse cardiovascular events were consistent in patients with (hazard ratio [HR]: 0.81 [95% confidence interval (CI): 0.65 to 1.02]) and without (HR: 0.88 [95% CI: 0.78 to 1.00]) a history of HF (p interaction = 0.53). In both subgroups, fewer deaths were observed with liraglutide (HR: 0.89 [95% CI: 0.70 to 1.14] with HF; HR: 0.83 [95% CI: 0.70 to 0.97] without HF; p interaction = 0.63) versus placebo. No increased risk of HF hospitalization was observed with liraglutide, regardless of HF history (HR: 0.98 [95% CI: 0.75 to 1.28] with HF; HR: 0.78 [95% CI: 0.61 to 1.00] without HF; p interaction = 0.22). Effects of liraglutide on the composite of HF hospitalization or cardiovascular death were consistent in patients with (HR: 0.92 [95% CI: 0.74 to 1.15]) and without (HR: 0.77 [95% CI: 0.65 to 0.91]) a history of HF (p interaction = 0.19)., Conclusions: Based on these findings, liraglutide should be considered suitable for patients with T2D with or without a history of NYHA functional class I to III HF. (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results [LEADER]; NCT01179048)., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
14. In Memoriam: Sandy Ford (1950–2015).
- Author
-
Schultz MG and Bloch AB
- Subjects
- Acquired Immunodeficiency Syndrome diagnosis, Acquired Immunodeficiency Syndrome drug therapy, Antifungal Agents therapeutic use, History, 20th Century, History, 21st Century, Humans, Pentamidine therapeutic use, Pneumonia, Pneumocystis diagnosis, Pneumonia, Pneumocystis drug therapy, United States, Acquired Immunodeficiency Syndrome history, Antifungal Agents history, Centers for Disease Control and Prevention, U.S. history, Pentamidine history, Pharmacy Technicians history, Pneumonia, Pneumocystis history
- Published
- 2016
- Full Text
- View/download PDF
15. Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells.
- Author
-
Zaina S, Pettersson L, Thomsen AB, Chai CM, Qi Z, Thyberg J, and Nilsson J
- Subjects
- Animals, Aorta pathology, Blood Pressure, Body Constitution, Bradycardia mortality, Bradycardia pathology, Electrocardiography, Female, Gene Expression physiology, Heart Defects, Congenital mortality, Heart Defects, Congenital pathology, Heart Defects, Congenital physiopathology, Heterozygote, Hypotension mortality, Hypotension pathology, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Myocytes, Smooth Muscle pathology, Phenotype, Sex Distribution, Survival Rate, Transgenes physiology, Bradycardia physiopathology, Hypotension physiopathology, Insulin-Like Growth Factor II genetics, Longevity physiology, Myocytes, Smooth Muscle physiology
- Abstract
IGF2 is known to affect the normal development and pathology of the cardiovascular system. We previously created mutant mice with targeted expression of an Igf2 transgene in the smooth muscle cells and showed that these mice spontaneously develop aortic intimal cushions. In the present work, we provide a general description of the phenotype of two independent lines of heterozygous transgenics. These mice showed organomegaly and a shortened life span. The latter trait was stronger in the line with a relatively more marked organomegaly and more pronounced in males than females in both lines. Postmortem histology revealed gross abnormalities of the cardiac architecture, suggesting that transgenic mice may accumulate lethal cardiovascular defects. Accordingly, apparently normal transgenic mice had mild cardiomegaly, an enlarged left ventricle, bradycardia, and hypotension. These observations are discussed in the light of the proposed therapeutic use of IGF2 in human cardiac diseases.
- Published
- 2003
- Full Text
- View/download PDF
16. The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey.
- Author
-
Smith PJ, Schwartz B, Mokdad A, Bloch AB, McCauley M, and Murphy TV
- Subjects
- Administration, Oral, Child, Preschool, Cohort Studies, Female, Health Care Surveys, Humans, Infant, Intussusception epidemiology, Male, Population Surveillance, Risk Assessment, Risk Factors, Rotavirus Vaccines administration & dosage, Rotavirus Vaccines supply & distribution, United States epidemiology, Vaccines, Attenuated adverse effects, Immunization Programs statistics & numerical data, Intussusception etiology, Rotavirus Infections prevention & control, Rotavirus Vaccines adverse effects
- Abstract
Objective: On August 31, 1998, the rhesus-human reassortant rotavirus vaccine (RRV-TV) was licensed for use in the U.S. During the next nine months, 15 cases of intussusception were reported among infants who received the vaccine. Case-control and cohort studies showed a significantly increased risk of developing intussusception within one week of receiving the vaccine; subsequent ecologic studies did not. In this study, the authors used data on RRV-TV vaccination rates from the National Immunization Survey (NIS) to estimate state and national RRV-TV uptake rates and factors associated with receiving RRV-TV. These estimates are a key component in evaluating published ecologic studies designed to investigate the relationship between receipt of the vaccine and intussusception., Methods: The authors analyzed NIS data for children ages 19 to 35 months who were eligible to receive RRV-TV between September 1998 and July 1999. The authors estimated vaccine coverage and the number of doses administered by state, NIS sampling quarter, and birth cohort, and analyzed demographic and socioeconomic variables to evaluate their relationship with receiving RRV-TV., Results: It was estimated that approximately 1 million doses of RRV-TV were administered to 504,585 (+/-61,854) children, 13.4% (+/-1.6%) of children who were eligible. The estimated number of doses administered and the vaccination coverage rate varied greatly from state to state. Children living in households with higher socioeconomic conditions were more likely to receive the vaccine., Conclusion: Ecologic studies had a limited ability to detect a significant increase in the population incidence rate of intussusception that could be attributed to RRV-TV because populations in these studies consisted primarily of children who did not receive the vaccine. The example from RRV-TV demonstrates some of the challenges of assessing the magnitude of the association between a vaccine and an uncommon or rare adverse event.
- Published
- 2003
- Full Text
- View/download PDF
17. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities.
- Author
-
Hutton MD, Cauthen GM, and Bloch AB
- Subjects
- Adolescent, Adult, Age Factors, Aged, Child, Child, Preschool, Female, Health Surveys, Humans, Incidence, Infant, Infant, Newborn, Male, Middle Aged, Tuberculosis prevention & control, United States epidemiology, Nursing Homes statistics & numerical data, Prisons statistics & numerical data, Tuberculosis epidemiology
- Abstract
A survey of the 15,379 cases of tuberculosis reported to the Centers for Disease Control and Prevention by 29 State health departments in 1984 and 1985 revealed that 7.7 percent of the victims older than age 64 were living in a nursing home at the time of diagnosis and 1.8 percent between the ages of 15 and 64 were living in a correctional institution at the time of diagnosis. Incidence rates of tuberculosis for residents of nursing homes and for inmates of Federal and State prisons and local jails were estimated using denominators derived from institutional population counts provided by the National Center for Health Statistics and by the Department of Justice, Bureau of Justice Statistics, and Bureau of Prisons. The aggregate tuberculosis incidence rate for nursing home residents in the 29 States was 1.8 times higher than the rate seen in elderly persons who were living in the community (95 percent confidence interval on the relative risk 1.64, 2.02). The aggregate tuberculosis incidence rate for inmates in correctional facilities was 3.9 times higher than the rate for persons of a similar age who were not incarcerated (95 percent confidence interval on the relative risk 3.35, 4.49). Strengths and limitations of the design and implications of the first survey of tuberculosis incidence, in a large number of States, among residents of nursing homes and correctional facilities are discussed.
- Published
- 1993
18. Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A.
- Author
-
Bloch AB, Stramer SL, Smith JD, Margolis HS, Fields HA, McKinley TW, Gerba CP, Maynard JE, and Sikes RK
- Subjects
- Adult, Antigens, Viral isolation & purification, Cells, Cultured, Epidemiologic Methods, Georgia, Hepatitis A Antigens, Hepatovirus immunology, Humans, Male, Virus Cultivation, Water Supply, Disease Outbreaks, Hepatitis A epidemiology, Hepatovirus isolation & purification, Water Microbiology
- Abstract
An outbreak of hepatitis A occurred in a north Georgia trailer park served by a private well. Of 18 residents who were serosusceptible to hepatitis A virus (HAV), 16 (89%) developed hepatitis A. Well water samples were collected 3 months after illness onset in the index case and 28 days after illness onset in the last trailer park resident. Hepatitis A virus antigen (HAVAg) was detected in the samples by enzyme immunoassay from three of the five cell lines following two 30-day passages and from a fourth cell line following a third passage of 21 days.
- Published
- 1990
- Full Text
- View/download PDF
19. Estimating HIV levels and trends among patients of tuberculosis clinics.
- Author
-
McCray E, Onorato IM, Miller BI, Dondero TJ Jr, and Bloch AB
- Subjects
- AIDS Serodiagnosis methods, Acquired Immunodeficiency Syndrome prevention & control, Adult, Ambulatory Care Facilities, HIV Seropositivity epidemiology, Humans, Middle Aged, Population Surveillance methods, Risk Factors, Sampling Studies, Tuberculosis complications, Tuberculosis prevention & control, United States epidemiology, HIV Seroprevalence, Tuberculosis immunology
- Abstract
Symptomatic tuberculosis (TB) can occur as an opportunistic disease in immunosuppressed persons who are infected with human immunodeficiency virus (HIV) and who have been previously infected with Mycobacterium tuberculosis. Increases in TB cases have occurred in areas which have reported large numbers of cases of the acquired immunodeficiency syndrome (AIDS), and a high proportion of these TB cases have been HIV seropositive. Therefore, increasing numbers of HIV-infected persons may be found in TB clinics and hospitals. HIV serologic surveys in TB clinics and hospitals providing clinical services to TB patients are needed to assess the local prevalence of HIV infection in TB patients and the consequent need for public health intervention to prevent further spread of HIV and TB infection. The Centers for Disease Control (CDC), in collaboration with State and local health departments, has initiated HIV surveillance of patients with confirmed and suspected TB in TB clinics and hospitals in the United States. Blinded (serologic test results not linked to identifiable persons) HIV seroprevalence surveys are conducted in sentinel TB clinics and hospitals that provide TB clinical services each year to obtain estimates of the level of HIV infection in TB patients and to follow trends in infection over time. Nonblinded (voluntary) surveys will also be conducted to evaluate behaviors that have placed TB patients at risk for or protected them against HIV infection. Data from these surveys will be used to target education and prevention and control programs for TB and HIV infection and to monitor changes in behavior in response to such programs.
- Published
- 1990
20. Impact of measles in the United States.
- Author
-
Hinman AR, Orenstein WA, Bloch AB, Bart KJ, Eddins DL, Amler RW, and Kirby CD
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Disease Outbreaks epidemiology, Encephalitis epidemiology, Encephalitis etiology, Humans, Infant, Measles complications, Measles economics, Measles prevention & control, Subacute Sclerosing Panencephalitis epidemiology, Subacute Sclerosing Panencephalitis etiology, United States, Vaccination, Measles epidemiology
- Abstract
Measles has had a severe impact on children in the United States since colonial times. In the early decades of the 20th century, thousands of fatal measles infections were reported each year. During the 1950s an annual average of greater than 500,000 cases of measles and nearly 500 deaths due to measles were reported in the United States. Surveys indicated that 95% of the population had been infected with measles by the age of 15 years. The introduction of measles vaccine and its widespread use, which began in 1963, has had a major impact on the occurrence of measles in the United States. Reported numbers of cases, deaths due to measles, and complications of measles (e.g., encephalitis) have declined dramatically. Accompanying the decline in reported incidence of measles and following it by approximately seven years, has been a decline in the reported incidence of subacute sclerosing panencephalitis (SSPE). In recent years, the incidence of measles has dropped to levels that are less than 1% of those seen in the prevaccine era. In 1981, provisional figures indicated that only 10% of counties in the United States reported any cases of measles. The reported incidence in 1981 was 1.3 cases per 100,000 population, compared with an average incidence of 336.3 cases per 100,000 population in the decade 1950-1959. Thus, the impact of measles in the United States has been markedly reduced, and it is anticipated that indigenous transmission will be eliminated entirely from the country within the year.
- Published
- 1983
- Full Text
- View/download PDF
21. How much tuberculosis in children must we accept?
- Author
-
Bloch AB and Snider DE Jr
- Subjects
- Adolescent, Child, Child, Preschool, Humans, United States, Tuberculosis epidemiology
- Published
- 1986
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.